Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-02 03:49:10 UTC |
---|
Updated at | 2022-09-02 03:49:10 UTC |
---|
NP-MRD ID | NP0148109 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | {[(4e,6r,8s,9s,10e,12s,13r,14s,16r)-3,6,13,22-tetrahydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-20,21-dioxo-2-azabicyclo[16.3.1]docosa-1(22),2,4,10,18-pentaen-9-yl]oxy}methanimidic acid |
---|
Description | Geldanamycin D belongs to the class of organic compounds known as vinylogous acids. These are organic compounds containing a hydroxyl group, which is indirectly attached to a carbonyl via an intervening vinyl (>C=C<) moiety. It was first documented in 2014 (PMID: 25374192). Based on a literature review a significant number of articles have been published on Geldanamycin D (PMID: 28140487) (PMID: 33979675) (PMID: 36045611) (PMID: 33406123) (PMID: 32845578) (PMID: 32497199). |
---|
Structure | CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C(=O)C(N=C(O)\C(C)=C\[C@H](O)C[C@H](OC)[C@@H](OC(O)=N)\C(C)=C\[C@H](C)[C@H]1O)=C2O InChI=1S/C29H42N2O11/c1-13-8-18-23(34)21(24(35)25(36)27(18)41-7)31-28(37)16(4)11-17(32)12-20(40-6)26(42-29(30)38)15(3)10-14(2)22(33)19(9-13)39-5/h10-11,13-14,17,19-20,22,26,32-34H,8-9,12H2,1-7H3,(H2,30,38)(H,31,37)/b15-10+,16-11+/t13-,14+,17+,19+,20+,22-,26+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C29H42N2O11 |
---|
Average Mass | 594.6580 Da |
---|
Monoisotopic Mass | 594.27886 Da |
---|
IUPAC Name | {[(4E,6R,8S,9S,10E,12S,13R,14S,16R)-3,6,13,22-tetrahydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-20,21-dioxo-2-azabicyclo[16.3.1]docosa-1(22),2,4,10,18-pentaen-9-yl]oxy}methanimidic acid |
---|
Traditional Name | {[(4E,6R,8S,9S,10E,12S,13R,14S,16R)-3,6,13,22-tetrahydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-20,21-dioxo-2-azabicyclo[16.3.1]docosa-1(22),2,4,10,18-pentaen-9-yl]oxy}methanimidic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C(=O)C(N=C(O)\C(C)=C\[C@H](O)C[C@H](OC)[C@@H](OC(O)=N)\C(C)=C\[C@H](C)[C@H]1O)=C2O |
---|
InChI Identifier | InChI=1S/C29H42N2O11/c1-13-8-18-23(34)21(24(35)25(36)27(18)41-7)31-28(37)16(4)11-17(32)12-20(40-6)26(42-29(30)38)15(3)10-14(2)22(33)19(9-13)39-5/h10-11,13-14,17,19-20,22,26,32-34H,8-9,12H2,1-7H3,(H2,30,38)(H,31,37)/b15-10+,16-11+/t13-,14+,17+,19+,20+,22-,26+/m1/s1 |
---|
InChI Key | XKJMWIBJSIVCQH-ARYQHHOHSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as vinylogous acids. These are organic compounds containing a hydroxyl group, which is indirectly attached to a carbonyl via an intervening vinyl (>C=C<) moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Vinylogous acids |
---|
Sub Class | Not Available |
---|
Direct Parent | Vinylogous acids |
---|
Alternative Parents | |
---|
Substituents | - Vinylogous acid
- Cyclic carboximidic acid
- Cyclic ketone
- Secondary alcohol
- Ketone
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Polyol
- Ether
- Dialkyl ether
- Carboximidic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Imine
- Carbonyl group
- Alcohol
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Wang X, Zhang Y, Ponomareva LV, Qiu Q, Woodcock R, Elshahawi SI, Chen X, Zhou Z, Hatcher BE, Hower JC, Zhan CG, Parkin S, Kharel MK, Voss SR, Shaaban KA, Thorson JS: Mccrearamycins A-D, Geldanamycin-Derived Cyclopentenone Macrolactams from an Eastern Kentucky Abandoned Coal Mine Microbe. Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2994-2998. doi: 10.1002/anie.201612447. Epub 2017 Jan 31. [PubMed:28140487 ]
- Mohan CD, Rangappa S, Nayak SC, Jadimurthy R, Wang L, Sethi G, Garg M, Rangappa KS: Bacteria as a treasure house of secondary metabolites with anticancer potential. Semin Cancer Biol. 2021 May 9. pii: S1044-579X(21)00134-6. doi: 10.1016/j.semcancer.2021.05.006. [PubMed:33979675 ]
- Wang G, Qu F, Zhou J, Zhu B, Gao Y: Elevated THBS3 predicts poor overall survival for clear cell renal cell carcinoma and identifies LncRNA/RBP/THBS3 mRNA networks. Cell Cycle. 2023 Feb;22(3):316-330. doi: 10.1080/15384101.2022.2117910. Epub 2022 Aug 31. [PubMed:36045611 ]
- Nonaka M, Mabashi-Asazuma H, Jarvis DL, Yamasaki K, Akama TO, Nagaoka M, Sasai T, Kimura-Takagi I, Suwa Y, Yaegashi T, Huang CT, Nishizawa-Harada C, Fukuda MN: Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides. PLoS One. 2021 Jan 6;16(1):e0241157. doi: 10.1371/journal.pone.0241157. eCollection 2021. [PubMed:33406123 ]
- McGarr GW, Fujii N, Schmidt MD, Muia CM, Kenny GP: Heat shock protein 90 modulates cutaneous vasodilation during an exercise-heat stress, but not during passive whole-body heating in young women. Physiol Rep. 2020 Aug;8(16):e14552. doi: 10.14814/phy2.14552. [PubMed:32845578 ]
- Zhou Z, Li X, Qian Y, Liu C, Huang X, Fu M: Heat shock protein 90 inhibitors suppress pyroptosis in THP-1 cells. Biochem J. 2020 Oct 30;477(20):3923-3934. doi: 10.1042/BCJ20200351. [PubMed:32497199 ]
- Jogula S, Soorneedi AR, Gaddam J, Chamakuri S, Deora GS, Indarapu RK, Ramgopal MK, Dravida S, Arya P: Geldanamycin-inspired compounds induce direct trans-differentiation of human mesenchymal stem cells to neurons. Eur J Med Chem. 2017 Jul 28;135:110-116. doi: 10.1016/j.ejmech.2017.03.082. Epub 2017 Apr 18. [PubMed:28441579 ]
- Liu Q, Lin Q, Li X, Ali M, He J: Construction and application of a "superplasmid" for enhanced production of antibiotics. Appl Microbiol Biotechnol. 2020 Feb;104(4):1647-1660. doi: 10.1007/s00253-019-10283-6. Epub 2019 Dec 18. [PubMed:31853567 ]
- Samakovli D, Roka L, Plitsi PK, Kaltsa I, Daras G, Milioni D, Hatzopoulos P: Active BR signalling adjusts the subcellular localisation of BES1/HSP90 complex formation. Plant Biol (Stuttg). 2020 Jan;22(1):129-133. doi: 10.1111/plb.13040. Epub 2019 Sep 27. [PubMed:31469500 ]
- Cuyas E, Verdura S, Micol V, Joven J, Bosch-Barrera J, Encinar JA, Menendez JA: Revisiting silibinin as a novobiocin-like Hsp90 C-terminal inhibitor: Computational modeling and experimental validation. Food Chem Toxicol. 2019 Oct;132:110645. doi: 10.1016/j.fct.2019.110645. Epub 2019 Jun 26. [PubMed:31254591 ]
- Fujii N, McGarr GW, Hatam K, Chandran N, Muia CM, Nishiyasu T, Boulay P, Ghassa R, Kenny GP: Heat shock protein 90 does not contribute to cutaneous vasodilatation in older adults during heat stress. Microcirculation. 2019 Aug;26(6):e12541. doi: 10.1111/micc.12541. Epub 2019 Apr 29. [PubMed:30828931 ]
- Li Y, Cao TT, Guo S, Zhong Q, Li CH, Li Y, Dong L, Zheng S, Wang G, Yin SF: Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition. Molecules. 2016 Jun 20;21(6):771. doi: 10.3390/molecules21060771. [PubMed:27331805 ]
- Migita K, Ozaki T, Shimoyama S, Yamada J, Nikaido Y, Furukawa T, Shiba Y, Egan TM, Ueno S: HSP90 Regulation of P2X7 Receptor Function Requires an Intact Cytoplasmic C-Terminus. Mol Pharmacol. 2016 Aug;90(2):116-26. doi: 10.1124/mol.115.102988. Epub 2016 Jun 14. [PubMed:27301716 ]
- Mellatyar H, Talaei S, Nejati-Koshki K, Akbarzadeh A: Targeting HSP90 Gene Expression with 17-DMAG Nanoparticles in Breast Cancer Cells. Asian Pac J Cancer Prev. 2016;17(5):2453-7. [PubMed:27268613 ]
- Katane M, Kaneko Y, Watanabe M, Doi Y, Tanaka T, Kasuga Y, Yoshida N, Kumakubo S, Nakayama K, Matsuda S, Furuchi T, Saitoh Y, Sekine M, Koyama N, Tomoda H, Homma H: Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells. Bioorg Med Chem Lett. 2016 Jan 15;26(2):556-560. doi: 10.1016/j.bmcl.2015.11.073. Epub 2015 Nov 28. [PubMed:26642769 ]
- Huo Q, Li HM, Lee JK, Li J, Ma T, Zhang X, Dai Y, Hong YS, Wu CZ: Biosynthesis of Novel Glucosides Geldanamycin Analogs by Enzymatic Synthesis. J Microbiol Biotechnol. 2016 Jan;26(1):56-60. doi: 10.4014/jmb.1508.08069. [PubMed:26464380 ]
- Hu Y, Bobb D, He J, Hill DA, Dome JS: The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. Cancer Biol Ther. 2015;16(6):949-57. doi: 10.1080/15384047.2015.1040964. Epub 2015 Apr 28. [PubMed:25920748 ]
- Hall JA, Seedarala S, Rice N, Kopel L, Halaweish F, Blagg BS: Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery. J Nat Prod. 2015 Apr 24;78(4):873-9. doi: 10.1021/acs.jnatprod.5b00054. Epub 2015 Mar 10. [PubMed:25756299 ]
- Lee JM, Lee JM, Kim KR, Im H, Kim YH: Zinc preconditioning protects against neuronal apoptosis through the mitogen-activated protein kinase-mediated induction of heat shock protein 70. Biochem Biophys Res Commun. 2015 Apr 3;459(2):220-226. doi: 10.1016/j.bbrc.2015.02.068. Epub 2015 Feb 21. [PubMed:25712525 ]
- Mellatyar H, Akbarzadeh A, Rahmati M, Ghalhar MG, Etemadi A, Nejati-Koshki K, Zarghami N, Barkhordari A: Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pac J Cancer Prev. 2014;15(20):8693-8. doi: 10.7314/apjcp.2014.15.20.8693. [PubMed:25374192 ]
- LOTUS database [Link]
|
---|